Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 6 | BMC Cancer

Fig. 6

From: Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection

Fig. 6

SLC39A6 silencing significantly decreases gastric cancer cell proliferation. a-b Quantitative RT-PCR shows that transfection of gastric cancer cell lines BGC-823 and SGC-7901 with SLC39A6 siRNA1 and siRNA2 significantly suppressed SLC39A6 expression. a Levels of SLC39A6 mRNA. b Extent of SLC39A6 knockdown achieved with each siRNA. c-d SLC39A6 knockdown inhibited proliferation of c BGC-823 and d SGC-7901 cells (p < 0.05 vs. control cells untransfected (Mock) or transfected with scrambled siRNA (NC))

Back to article page